(Q45830226)

16 December 2017

title

Modification of hepatitis B virus infection by recombinant leukocyte alpha A interferon (English)

1 reference

16 December 2017

Karl-Hermann Meyer zum Büschenfelde

1 reference

series ordinal

2

object named as

Meyer zum Büschenfelde KH

1 reference

16 December 2017

author name string

Hess G

series ordinal

1

1 reference

16 December 2017

publication date

1 September 1986

1 reference

16 December 2017

published in

Immunobiology

1 reference

16 December 2017

volume

172

1 reference

16 December 2017

issue

3-5

1 reference

16 December 2017

page(s)

255-261

1 reference

16 December 2017

Deleterious effect of prednisolone in HBsAg-positive chronic active hepatitis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2886%2980106-1

7 January 2021

Discontinuation of immunosuppressive therapy in hepatitis B surface antigen-positive chronic hepatitis: effect on viral replication and on liver cell damage

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2886%2980106-1

7 January 2021

Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2886%2980106-1

7 January 2021

HBsAg-positive chronic liver disease: inhibition of DNA polymerase activity by vidarabine.

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2886%2980106-1

7 January 2021

Administration of human fibroblast interferon in chronic hepatitis-B infection

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2886%2980106-1

7 January 2021

Production of interferon alpha and interferon gamma by peripheral blood leukocytes from patients with chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2886%2980106-1

7 January 2021

Interferon in chronic hepatitis B infection

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2886%2980106-1

7 January 2021

Natural history of chronic hepatitis B virus infection in Taiwan: studies of hepatitis B virus DNA in serum

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2886%2980106-1

7 January 2021

Seroconversion from Hepatitis B e Antigen to Antibody in Chronic Type B Hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2886%2980106-1

7 January 2021

Recombinant leukocyte a interferon treatment in patients with chronic hepatitis B virus infection. Pharmacokinetics, tolerance, and biologic effects

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2886%2980106-1

7 January 2021

Acyclovir enhances the antiviral effect of interferon in chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2886%2980106-1

7 January 2021

10.1016/S0171-2985(86)80106-1

Identifiers

DOI

0 references

1 reference

16 December 2017